TrialBone marrow transplantation2019

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties.

Peter Dreger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.